NIH Weekly Funding Opportunities and Policy Notices

Thursday, March 30, 2017 - 9:11am
Funding Opportunity PAR-17-240 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for the development of innovative research projects in cancer nanotechnology. This initiative, to be known as Innovative Research in Cancer Nanotechnology (IRCN), is a component of a broader program that is the NCI Alliance for Nanotechnology in Cancer. IRCN awards are designed to enable multidisciplinary research and transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. This scope includes research concerning the delivery of nanoparticles and/or nanodevices to desired and intended cancer targets in vivo and/or characterization of in vitro detection and diagnostic devices.
Thursday, March 30, 2017 - 8:57am
Funding Opportunity RFA-NS-17-010 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications to continue support of a national program of mentored research career development for junior neurosurgeon faculty at institutions nationwide that support neurosurgical research. The goal of the program is to expand the cadre of neurosurgeon investigators trained to conduct research into neurological disorders, making use of their neurosurgical training.
Wednesday, March 29, 2017 - 11:15pm
Funding Opportunity RFA-HL-18-014 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to establish up to four Centers for the Investigation of Factor VIII immunogenicity (FVIII Centers). These Centers will utilize cross-disciplinary science and novel technologies to define the basic mechanisms involved in the development of anti-FVIII neutralizing antibodies, also known as FVIII inhibitors, in patients with congenital hemophilia A.
Wednesday, March 29, 2017 - 11:09pm
Funding Opportunity PAR-17-237 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Centers for AIDS Research (CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research. CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.
Wednesday, March 29, 2017 - 11:08pm
Funding Opportunity PAR-17-238 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Developmental Centers for AIDS Research (D-CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research. D-CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. Additionally, D-CFARs provide support to assist investigators in the development of a competitive standard CFAR. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.
Wednesday, March 29, 2017 - 10:06am
Funding Opportunity PA-17-232 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) solicits individual Mentored Clinical Scientist Research Career Development (K08) grant applications from applicant organizations. The overall goal of AHRQ-supported career development programs is to help ensure that a diverse pool of highly trained health services researchers are available in adequate numbers and in appropriate research areas to address the mission and priorities of AHRQ.
Wednesday, March 29, 2017 - 9:25am
Notice NOT-MH-17-016 from the NIH Guide for Grants and Contracts
Wednesday, March 29, 2017 - 9:14am
Notice NOT-AA-17-001 from the NIH Guide for Grants and Contracts
Wednesday, March 29, 2017 - 9:04am
Notice NOT-RM-17-014 from the NIH Guide for Grants and Contracts
Wednesday, March 29, 2017 - 8:51am
Notice NOT-RM-17-013 from the NIH Guide for Grants and Contracts
Wednesday, March 29, 2017 - 8:47am
Notice NOT-OD-17-051 from the NIH Guide for Grants and Contracts
Wednesday, March 29, 2017 - 8:38am
Notice NOT-DA-17-013 from the NIH Guide for Grants and Contracts
Wednesday, March 29, 2017 - 8:34am
Notice NOT-CA-17-044 from the NIH Guide for Grants and Contracts
Wednesday, March 29, 2017 - 8:19am
Notice NOT-AT-17-006 from the NIH Guide for Grants and Contracts
Wednesday, March 29, 2017 - 1:45am
Funding Opportunity PAR-17-235 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote exploratory and developmental research to understand the underlying mechanisms of sleep deficiencies among health disparity populations and how sleep deficiencies may lead to disparities in health outcomes.
Wednesday, March 29, 2017 - 1:45am
Funding Opportunity PAR-17-234 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote research to understand the underlying mechanisms of sleep deficiencies among health disparity populations and how sleep deficiencies may lead to disparities in health outcomes.
Wednesday, March 29, 2017 - 1:01am
Notice NOT-HS-17-011 from the NIH Guide for Grants and Contracts
Wednesday, March 29, 2017 - 12:41am
Funding Opportunity PAR-17-236 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support innovative applications that will inform our understanding of structural birth defects through the use of animal models in conjunction with translational/clinical approaches. Applicants are encouraged to take advantage of advances in genetics, biochemistry, molecular, and developmental biology to identify specific genetic, epigenetic, environmental, or gene/environment interactions associated with the susceptibility to and variability of structural birth defects in human populations. Applicants funded through this FOA will join the NICHD Birth Defects Working Group and participate in annual meetings designed to provide a forum to discuss research progress, exchange ideas, share resources, and foster collaborations relevant to the goals of the NICHD's Birth Defects Initiative.

Pages